Mitogen-Activated Protein Kinase Regulates Dopamine Transporter Surface Expression and Dopamine Transport Capacity

Abstract

The dopamine transporter (DAT) regulates the clearance of dopamine (DA) released into the extracellular space and is an important site on which psychostimulants act to produce their effects. Here, we show that mitogen-activated protein kinase (MAPK) regulates the transport capacity and intracellular trafficking of DAT. Incubation of striatal synaptosomes or epitope-tagged human DAT (hDAT) human embryonic kidney (HEK) 293 cells with the MAPK kinase (MEK) inhibitors 1,4-diamino-2,3-dicyano-1,4-bis(o-aminophenylmercapto) butadiene and 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one decreased DA uptake in a concentration- and time-dependent manner. Kinetic studies revealed a decrease in the capacity of transport (Vmax) but no change in Km. Immunoblotting confirmed labeling of p42 and p44 MAPK in untreated striatal synaptosomes and HEK 293 cells, consistent with constitutive MAPK activation, and the inhibitors used decreased MAPK phosphorylation. Biotinylation and confocal imaging studies showed that MAPK inhibition promoted the clathrin-associated redistribution of hDAT from the plasma membrane to the cytosol. In contrast, transient transfection of hDAT-expressing cells with constitutively active MEK increased the Vmax of DA transport without altering Km. However, only a small increase in hDAT cell surface expression was seen. These data demonstrate an involvement of the MAPK cascade in regulating DAT transport capacity in striatum and that inhibition of this cascade decreases DAT cell surface expression in HEK 293 cells. Furthermore, they highlight the potential role of MAPK as a presynaptic mechanism that regulates DA signaling.

A Role for p38 Mitogen-activated Protein Kinase-mediated Threonine 30-dependent Norepinephrine Transporter Regulation in Cocaine Sensitization and Conditioned Place Preference

“…All three monoamine transporters are regulated by p38 MAPK (1,23,52). In support of this, we found evidence for the association of phospho-p38 MAPK with NET, SERT, and DAT.…”

n-3 Polyunsaturated fatty acid deprivation in rats decreases frontal cortex BDNF via a p38 MAPK-dependent mechanism

“…15 Fluoxetine also activates the p38 MAPK cascade, 80 suggesting that the depressive symptoms observed in n-3 PUFA deprived rats are related to decreased p38 MAPK activity. Constitutive p38 MAPK activity maintains the expression of rat brain dopamine 81,82 and serotonin transporters 83 and n-3 PUFA deprivation upregulates D1 and D2 receptors 84 and decreases stimulated serotonin release, 85 all of which are believed to be involved in depression.…”

A Role for p38 Mitogen-Activated Protein Kinase in the Regulation of the Serotonin Transporter: Evidence for Distinct Cellular Mechanisms Involved in Transporter Surface Expression

“…Recently, a selective MEK inhibitor, PD98059, has been shown to downregulate dopamine transporter (DAT), suggesting a role for MEK1/2 in DAT regulation Moron et al, 2003); however, PD98059 had no effect on 5-HT transport. Similarly, SP600125, a specific inhibitor of JNK, also had no affect on 5-HT uptake.…”